Amedisys, Inc. (NASDAQ:AMED) Shares Sold by Magnetar Financial LLC

Magnetar Financial LLC reduced its stake in Amedisys, Inc. (NASDAQ:AMED) by 0.6% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 615,495 shares of the health services provider’s stock after selling 3,416 shares during the period. Amedisys makes up approximately 1.2% of Magnetar Financial LLC’s portfolio, making the stock its 28th biggest position. Magnetar Financial LLC owned about 1.88% of Amedisys worth $56,502,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors also recently bought and sold shares of the company. Skandinaviska Enskilda Banken AB publ lifted its holdings in shares of Amedisys by 43.7% in the 2nd quarter. Skandinaviska Enskilda Banken AB publ now owns 26,286 shares of the health services provider’s stock worth $2,414,000 after acquiring an additional 8,000 shares during the last quarter. Canada Pension Plan Investment Board raised its position in Amedisys by 61.0% in the second quarter. Canada Pension Plan Investment Board now owns 79,200 shares of the health services provider’s stock valued at $7,271,000 after purchasing an additional 30,000 shares during the period. Intech Investment Management LLC acquired a new position in Amedisys during the second quarter worth $280,000. Highbridge Capital Management LLC boosted its position in shares of Amedisys by 34.7% during the second quarter. Highbridge Capital Management LLC now owns 323,200 shares of the health services provider’s stock worth $29,670,000 after buying an additional 83,200 shares during the period. Finally, Vanguard Personalized Indexing Management LLC grew its stake in shares of Amedisys by 12.9% in the second quarter. Vanguard Personalized Indexing Management LLC now owns 5,421 shares of the health services provider’s stock valued at $498,000 after buying an additional 619 shares in the last quarter. Institutional investors and hedge funds own 94.36% of the company’s stock.

Wall Street Analyst Weigh In

AMED has been the topic of several research reports. Cantor Fitzgerald reissued a “neutral” rating and set a $101.00 target price on shares of Amedisys in a research note on Thursday, July 25th. Deutsche Bank Aktiengesellschaft cut shares of Amedisys from a “buy” rating to a “hold” rating and set a $101.00 price target on the stock. in a research report on Monday, July 29th. Finally, William Blair cut shares of Amedisys from an “outperform” rating to a “market perform” rating in a report on Monday, July 1st. Four investment analysts have rated the stock with a hold rating and two have given a buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and an average price target of $100.67.

Amedisys Price Performance

Shares of NASDAQ AMED opened at $97.30 on Monday. The stock’s 50-day moving average is $97.69 and its two-hundred day moving average is $94.84. The company has a debt-to-equity ratio of 0.30, a current ratio of 1.16 and a quick ratio of 1.16. The company has a market cap of $3.18 billion, a price-to-earnings ratio of -152.03, a price-to-earnings-growth ratio of 1.89 and a beta of 0.78. Amedisys, Inc. has a 1-year low of $89.55 and a 1-year high of $98.95.

Amedisys (NASDAQ:AMED) last released its earnings results on Wednesday, July 24th. The health services provider reported $1.32 earnings per share for the quarter, topping analysts’ consensus estimates of $1.22 by $0.10. Amedisys had a net margin of 4.02% and a return on equity of 12.39%. The firm had revenue of $591.19 million for the quarter, compared to analyst estimates of $579.34 million. Analysts forecast that Amedisys, Inc. will post 4.66 EPS for the current fiscal year.

Amedisys Company Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.